They Want Us Dead
Friendly Fire? Who Shot the Secret Service Officer During the WHCA Dinner?
Wait, There Was a Shooting Near the White House Two Weeks Ago...and the...
How You Know the Politico Story About Kash Patel's Impending Termination Is Fishy
CNN's Ben Ferguson Couldn't Believe Libs Had This Take About Jimmy Kimmel's Melania...
The Latest Update on the Third Trump Assassination Attempt Was Rather Disconcerting
At Long Last, Thom Tillis Will Vote to Confirm Trump's Fed Chair Pick
Democrats Always Act Surprised When One of Their Own Tries to Murder Trump
James Talarico's Spiritual Mentor Makes Vile Joke About the Latest Assassination Attempt A...
Leftist Fundamentals: Violence, Hatred, and Lying
They Could Do It, but You Wouldn't Like It
Dead Men Don’t Vote: Federal Oversight Is the Only Way to Clean Up...
Fund the Department of Homeland Security. Now.
Ongoing Netflix-Paramount Drama: When the Going Gets Tough, the Tough Hire Lobbyists to...
When Will Iran Erupt?
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos